I thought you were describing Oncosil for a moment:
"There are drug companies listed on the ASX with virtually no data. Proof of concept, maybe a piss ant Phase 1 study, most likely single arm as well."
Yep That's Oncosil.
"No Phase 2 study."
Yep That's Oncosil.
"No Phase 3 study." TICK
"And no RCT! All single arm with very low patient data." TICK AGAIN
"No Regulatory Approvals either. None. Let that sink in. None, zero, zilch."
Not quite true for Oncosil. They did get CE mark approval for Europe and will thus likely get regulatory approvals in other jurisdictions, but these are small impact approvals. How will Oncosil compete in those markets when competitors have claims to better results from phase 3 RCT trials?
"Hardly any cash in the bank either, many of these exploratory drug companies."
Yep That's Oncosil. They managed to snag another $19 million of cash.
"No likely revenue either. None. Zero. Zilch."
Yep. TICK AGAIN. Maybe a few sales but if those sales don't at least cover costs, then what's the point?
"CR almost a 100% certainty. Every year while they complete expensive trials."
TICK. I presume Oncosil will go for FDA approval...
"No guarantees they will succeed to Phase 2 or Phase 3 either. None, Zero, Zilch."
YES YESSS I agree!
All BS to me too!
- Forums
- ASX - By Stock
- OSL
- OSL Corpse
OSL Corpse, page-19
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.2¢ |
Change
0.002(15.0%) |
Mkt cap ! $43.51M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.1¢ | $123.5K | 11.18M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3585939 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 7434758 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 3585939 | 0.011 |
15 | 10706250 | 0.010 |
22 | 14670708 | 0.009 |
5 | 5537600 | 0.008 |
14 | 5041677 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 7434758 | 11 |
0.013 | 13031397 | 8 |
0.014 | 7564450 | 11 |
0.015 | 10079912 | 5 |
0.016 | 4641791 | 4 |
Last trade - 14.52pm 15/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online